Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pfizer’s Big Bet On Arena Pays Off With First Phase III Win For Etrasimod In UC
Top-Line Readout Follows Recent $6.7bn Acquisition
Mar 23 2022
•
By
Mandy Jackson
Pfizer turned over the first of two Phase III cards for etrasimod in ulcerative colitis • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D